Align Capital Partners’ toxicology testing services provider Premier Biotech has purchased Desert Tox LLC, a provider of Substance Abuse and Mental Health Services Administration (SAMHSA) certified laboratory testing services.

Desert Tox serves customers throughout the U.S. across a range of end markets, including HHS/DOT, employment, occupational health and government markets. Desert Tox looks to expand Premier’s service offering and customer relationships. Desert Tox marks Premier’s first add-on since ACP’s acquisition of the company in November of 2022.